Next-generation Nanovial Platforms for Function-first Discovery of Rare Antibodies and T-cell Receptors

Name: Next-generation Nanovial Platforms for Function-first Discovery of Rare Antibodies and T-cell Receptors — Partillion Bioscience - Unlocking Functional Single Cell Biology
Start: 2023-12-05T09:00:00-0800
End: 2023-12-05T09:55:00-0800

Tuesday, December 5, 2023
9:00 AM 9:55 AM

Google Calendar ICS

Webinar

Keynote Speaker: Dr. Dino Di Carlo, Armond and Elena Hairapetian Professor of Bioengineering at UCLA

Hosted by: SinoBiological

Nanovials make it possible to selectively bind and characterize the function of antigen-specific antibodies, cytokines, and other effector molecules. Plasma B cells, hybridomas, or T cells can be sorted for downstream sequencing and recovery of antibody heavy and light chains or T cell receptor (TCR) alpha and beta chains. By providing functional annotation in a high-throughput manner, Nanovials speed up the discovery of antibodies and cancer-specific TCRs, revolutionizing therapeutic antibody and T cell therapy development.

Next-generation Nanovial Platforms for Function-first Discovery of Rare Antibodies and T-cell Receptors

Accelerating the Discovery of Rare Antibodies and T-cell Receptors (TCRs) using Lab on a Particle Technology

Fully Human Antibody Discovery Using Nanovials and Plasma Cells From ATX-GKTM Mice

Stay Up to Date